Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NYSE:TMBR

Timber Pharmaceuticals (TMBR) Stock Price, News & Analysis

Timber Pharmaceuticals logo

About Timber Pharmaceuticals Stock (NYSE:TMBR)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.34
$2.94
52-Week Range
N/A
Volume
26,307 shs
Average Volume
511,937 shs
Market Capitalization
$1.21 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive TMBR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Timber Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

TMBR Stock News Headlines

I was wrong about Trump
I made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his advisors, I believed him. I believed the promise that he would finally confront the single most dangerous threat to American life. That he would fix the ticking time bomb I’ve been warning about for 15 years. But I was wrong.
Timber Pharmaceuticals Inc (TMBRQ)
See More Headlines

TMBR Stock Analysis - Frequently Asked Questions

Shares of Timber Pharmaceuticals reverse split before market open on Wednesday, November 9th 2022.The 1-50 reverse split was announced on Wednesday, November 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, November 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Timber Pharmaceuticals investors own include Zomedica (ZOM), Jumia Technologies (JMIA), Nano Dimension (NNDM), NIO (NIO), AST SpaceMobile (ASTS), Castor Maritime (CTRM) and Phunware (PHUN).

Company Calendar

Today
7/27/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Current Symbol
NYSE:TMBR
CIK
1504167
Fax
N/A
Employees
9
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$19.38 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-511.45%
Return on Assets
-180.93%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.50
Quick Ratio
0.50

Sales & Book Value

Annual Sales
$80 thousand
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$1.79 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
3,430,000
Free Float
3,378,000
Market Cap
$1.21 million
Optionable
Not Optionable
Beta
0.03
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NYSE:TMBR) was last updated on 7/27/2025 by MarketBeat.com Staff
From Our Partners